51 results
6-K
EX-99.1
IPHA
Innate Pharma
21 Mar 24
Summary of Consolidated Financial Statements and Notes
9:20am
and PACIFIC-9 launched in April 2022, and (ii) the decrease of the collaboration commitment ("collaboration liabilities" in the consolidated statements
6-K
EX-1.1
IPHA
Innate Pharma
6 Feb 24
Current report (foreign)
5:05pm
, New York 10022
[DATE]
RE: Innate Pharma S.A.
Ladies and Gentlemen,
In connection with its proposed commitment to subscribe for ordinary shares … each prospective investor before the Agent Notification
To: [ ]
In connection with our proposed commitment to subscribe for ordinary shares, nominal
F-3
EX-3.1
IPHA
Innate Pharma
20 Dec 23
Shelf registration (foreign)
4:45pm
-transferability commitment, so that the 2017 Preferred Shares for which they have requested the definitive allocation will freely become transferable.
3. 2017
6-K
EX-99.1
el866vit0ckclx8
14 Sep 23
Innate Pharma Reports First Half 2023 Financial Results and Business Update
6:27am
6-K
EX-99.2
qqegc247ipi9mvxcm8je
14 Sep 23
Innate Pharma Reports First Half 2023 Financial Results and Business Update
6:27am
6-K
EX-99.1
wn75bncpdasmef59tl
14 Sep 23
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
n9w581wwed5l5hu575
3 May 23
Innate Pharma S.a. 6-K
6:00am
6-K
EX-1.1
rqkuud1vy74g
26 Apr 23
Current report (foreign)
4:02pm
6-K
EX-99.1
kzvzb
19 Dec 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.2
a7z3xejmf0kvroy4pi
15 Sep 22
Innate Pharma Reports First Half 2022 Financial Results and Business Update
6:12am
6-K
EX-99.1
cqor3v
15 Sep 22
Innate Pharma Reports First Half 2022 Financial Results and Business Update
6:12am
6-K
EX-99.1
q20awxg
1 Aug 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
hwchfmy9 tjexs
20 May 22
Appointment of Dr Sally Bennett to the Supervisory Board
4:09pm
6-K
EX-1.1
eglkodnawgrt2od50i93
3 May 22
Current report (foreign)
5:08pm
6-K
EX-99.1
5zat686g8wxx
29 Apr 22
Innate Pharma S.a. 6-K
6:00am